Pfizer Inc. (NYSE: PFE) helped boost the Dow Jones Industrial Average (DJIA) the day after delivering a double beat in its ...

Pfizer (PFE) reported $17.56 billion in revenue for the quarter ended December 2025, representing a year-over-year decline of ...

Amazon’s ( AMZN) free cash flow is likely to turn negative due to aggressive AI capital expenditures, while Google’s parent ...

Of course, there are countless value stocks that are worth mentioning, but this is a concise list of the top 4 undervalued ...

The once high-flying Danish drugmaker has struggled to fend off rivals in the weight-loss industry, especially Eli Lilly, ...

Billionaire entrepreneur Elon Musk is combining his rocket company SpaceX with his artificial intelligence startup xAI, he ...

During a live event, Sumanta K. Pal and other oncologists discuss the safety and efficacy of belzutifan for advanced renal ...

Many Canadians hoping to pay down their credit cards when they refinance their mortgage are finding their options are more ...

Agomab Therapeutics and SpyGlass Pharma secured a combined $350 million in two separate initial public offerings on Thursday ...

“Out of friendship and respect for Prime Minister Modi and, as per his request, effective immediately, we agreed to a Trade ...

Alluvial Fund reported a record 41.2% net return for 2025. Read the full Q4 2025 partner letter for detailed portfolio ...

Akeso, Inc. (9926.HK) is pleased to announce that ivonescimab, its global first-in-class bispecific antibody targeting PD-1 and VEGF, has been granted its fifth Breakthrough Therapy Designation from ...